# Impact of The COVID-19 Pandemic on Salivary Gland-related Healthcare Interventions; A Systematic Review And Meta-analysis: -

**Authors:** Myle Akshay Kiran, Safa Saeed, Abeer Bin Nafisah, Abdulaziz Alqarni, Atheer Haif Alotaibi, Abdulaziz Saleh Alqahtan, Hend Aljadaan, Haya Bin Osayl, Maha Alsane, Norah Alsuhail, Nouf Alrawaf, Raghad Sanad Albalawi, Samar Ayed Alanazi, Raneem Aloufi

PMC · DOI: 10.31661/gmj.vi.3970 · Galen Medical Journal · 2025-07-29

## TL;DR

This study examines how the COVID-19 pandemic affected healthcare interventions related to salivary gland diseases, finding no significant overall changes but some increased procedural complications.

## Contribution

The paper provides the first systematic review and meta-analysis on the impact of the pandemic on salivary gland-related surgeries and treatments.

## Key findings

- The pooled odds ratio for salivary gland interventions during versus pre-COVID was not statistically significant.
- Subgroup analysis showed increased odds of wound dehiscence after parotid surgery during the pandemic.
- No significant differences were found in delayed cancer diagnosis or urgent sialendoscopy rates.

## Abstract

The emergence of SARS-CoV-2 variants has raised concerns regarding their
potential impact on perioperative outcomes. Its effect on patients
undergoing surgery for salivary
gland diseases remains unclear. This systematic review and meta-analysis
aimed to evaluate
the impact of the COVID-19 pandemic on salivary gland-related healthcare
interventions, including cancer treatments, sialendoscopy procedures, and
parotid surgery outcomes.

Following PRISMA guidelines, a systematic search was conducted in PubMed,
Embase, and Web of Science (2019–2025) for studies reporting pre- and
during-COVID data.
Two reviewers independently screened records, extracted data, and assessed
risk of bias using the Newcastle-Ottawa Scale. A random-effects
meta-analysis was performed to pool odds
ratios (ORs) for intervention outcomes.

Four studies (n=7,740 participants) were included. The pooled OR for salivary
gland interventions during versus pre-COVID was 1.08
(95% CI: 0.88–1.33, P=0.45), indicating no significant change, with moderate
heterogeneity
(I²=46%). Subgroup analyses revealed increased odds of wound dehiscence
post-parotid surgery (OR=4.40, 95% CI: 1.18–16.40) but no significant
differences in delayed cancer diagnosis
or urgent sialendoscopy.

The COVID-19 pandemic did not significantly alter overall salivary gland
intervention rates or adverse events, though some procedural complications
increased non-significantly. Limited evidence underscores the need for
larger, standardized
studies. While this shows that surgeons maintained quality of practice in
this era during the
COVID-19.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), salivary gland diseases (MESH:D012466), wound dehiscence (MESH:D013529), COVID (MESH:D000086382)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877332/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877332/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877332/full.md

---
Source: https://tomesphere.com/paper/PMC12877332